dbt Labs is a Enterprise Software founded in 2016, currently valued at $4.2B. IPO Status: Pre-IPO. IPO Readiness Score: 68/100 (C+).
dbt Labs IPO status, timeline, valuation and S-1 filing tracker. Last updated May 2026.
| Industry | Enterprise Software |
| Stage | Late Stage Venture |
| IPO Status | Pre-IPO |
| Valuation | $4.2B |
| Total Funding | $414.4M |
| Headquarters | Philadelphia, PA |
| IPO Readiness Score | 68/100 |
| Founded | 2016 |
Track dbt Labs IPO status, valuation updates, and S-1 filing milestones on TechStackIPO. Last updated May 2026.
Data transformation platform enabling analytics engineers to transform data in the warehouse.
dbt Labs is in the pre-IPO phase as of May 2026. The company has an IPO readiness score of 68/100, suggesting it may be 1–3 years from a public listing depending on market conditions and internal milestones. Pre-IPO companies at this stage typically evaluate market conditions, complete board appointments, and engage underwriters before initiating the formal S-1 filing process.
dbt Labs is valued at $4.2B based on the most recent private market data. The company has raised a total of $414.4M in funding. Private market valuations are determined by the latest funding round and may differ from eventual IPO pricing, which reflects public market conditions, investor demand, and comparable company multiples at the time of listing.
Accredited investors may be able to access dbt Labs pre-IPO shares through secondary market platforms. These platforms facilitate private share transactions between existing shareholders (employees, early investors) and new buyers.
Risk factors: Pre-IPO investments are illiquid, carry higher risk than public market investments, and are typically restricted to accredited investors. Share availability and pricing depend on current shareholders willing to sell. TechStackIPO provides data and tracking tools but does not facilitate or recommend investments.
Funding rounds from seed through latest — Series A, B, C and beyond.
| Round | Date | Amount | Valuation | Lead Investor(s) |
|---|---|---|---|---|
| Series A | Jan 2020 | $12.9M | $100M | Andreessen Horowitz |
| Series B | Sep 2020 | $30M | $320M | Andreessen Horowitz |
| Series C | Jun 2021 | $150M | $1.55B | Altimeter Capital, Sequoia Capital |
| Series D | Feb 2022 | $222M | $4.2B | Altimeter Capital, Databricks Ventures |
Total funding raised: $414.4M
Bear / base / bull scenarios based on current private market valuation and comparable IPO multiples.
| Scenario | Est. Valuation | Basis |
|---|---|---|
| Bear | $3.1B | Compressed multiples, delayed listing |
| Base | $4.2B | Last private round valuation |
| Bull | $5.9B | Strong market, premium AI/tech multiple |
Estimates are illustrative. Not investment advice. All figures based on publicly available data.
dbt Labs has an IPO readiness score of 68/100 on TechStackIPO. A moderate readiness score suggests the company may be 2–4 years from IPO.
dbt Labs's last known private valuation is $4.2B. IPO valuations typically reflect current market conditions at time of listing and may differ from private market valuations.
Pre-IPO access options may include: (1) secondary market platforms such as Forge Global or EquityZen that facilitate private share sales, (2) ETFs holding pre-IPO companies or venture portfolios, and (3) direct secondary share purchases if eligible as an accredited investor. TechStackIPO tracks availability but does not facilitate investments.
No. dbt Labs has not yet filed an S-1 registration statement with the SEC as of TechStackIPO's latest data update.
dbt Labs operates in the Enterprise Software sector. TechStackIPO tracks multiple Enterprise Software companies from seed through IPO, including their funding rounds, valuations, and IPO readiness scores. You can compare dbt Labs against other Enterprise Software companies using TechStackIPO's comparison tool.
dbt Labs is at the Late Stage Venture stage. The company has raised a total of $414.4M in funding. Companies at this funding stage are typically scaling operations, expanding market share, and evaluating public market timing.
dbt Labs is headquartered in Philadelphia, PA. The company's location can influence IPO exchange selection, regulatory requirements, and investor interest. Companies headquartered in major tech hubs often benefit from proximity to venture capital networks and talent pools.